EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 1.2% of their position (20K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $4.2K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/21/2025ACC: 0001493152-25-003058
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+20K
Net shares
Net buyer
$4.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$0.21
Trade value
$4.24K
% of position
1.2%
11/21/2024
1.64M→1.66M
Total
Net shares
+20K
Net value
$4.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2024 | P · Purchase | +20K | $0.21 | $4.24K | 1.2% | 1.64M | 1.66M |
| Total | +20K | $4.24K | ||||||
Derivative Transactions0
No derivative transactions reported